Table 7.
The participants’ medical history and results from the initial medical examinations before commencement of the study
| Subjects (N = 19) | ||
|---|---|---|
| Age (median, min–max) | 29 (20–55) | |
| Female (N, %) | 9 (47%) | |
| Previous smoker (N, %)* | 7 (37%) | |
| Medical history | History of any symptoms last 12 months (N, %) | 7 (37%) |
| Eye symptoms (N, %) | 1 (5%) | |
| Nasal symptoms (N, %) | 3 (16%) | |
| Dry cough (N, %) | 0 | |
| History of chronic bronchitis symptoms (N, %) | 0 | |
| History of bronchial hyperreactivity symptoms (N, %) | 5 (26%) | |
| History of childhood atopy | Atopic dermatitis/Childhood eczema (N, %) | 3 (16%) |
| Allergic rhinitis/Hay fever (N, %) | 1 (5%) | |
| Urticaria (N, %) | 1 (5%) | |
| Physician-diagnosed asthma during childhood (N, %) | 1 (5%) | |
| Atopy | Phadiatop positive (N, %) | 7 (37%) |
| Baseline spirometry (prior to bronchodilation) | FVC % pred. (median, min–max) | 92 (70–106) |
| FEV1% pred. (median, min–max) | 94 (73–108) | |
| FEV1/FVC % pred. (median, min–max) | 100 (90–108) | |
| Baseline spirometry (after bronchodilation) | FVC % pred. (median, min–max) | 95 (72–107) |
| FEV1% pred. (median, min–max) | 97 (79–109) | |
| FEV1/FVC % pred. (median, min–max) | 100 (90–112) |
*All test subjects were currently non-smokers
FVC = forced vital capacity, FEV1 = forced expiratory volume in one second